Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPBWR1 | P48145 | 16/20 | 0.59 |
| ▸ | MCHR1 | Q99705 | 13/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | DCTPP1 | Q9H773 | 1/20 | 0.42 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4672514 | 0.90 | NPBWR1 (0.47) | NPBWR1MCHR1NPSR1ALDH1A1SMN1; SMN2 | |
| SCHEMBL4670179 | 0.89 | NPBWR1 (0.62) | NPBWR1MCHR1NPSR1SMN1; SMN2 | |
| SCHEMBL4930954 | 0.89 | NPBWR1 (0.55) | NPBWR1MCHR1NPSR1 | |
| SCHEMBL14282347 | 0.86 | MCHR1 (0.56) | NPBWR1MCHR1NPSR1ALDH1A1SMN1; SMN2 | |
| SCHEMBL4900987 | 0.86 | NPBWR1 (0.59) | NPBWR1MCHR1NPSR1 | |
| SCHEMBL14282364 | 0.86 | NPBWR1 (0.61) | NPBWR1MCHR1NPSR1 | |
| SCHEMBL14282362 | 0.86 | MCHR1 (0.55) | NPBWR1MCHR1NPSR1ALDH1A1SMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL4674011 | 0.86 | NPBWR1 (0.58) | NPBWR1MCHR1NPSR1 | |
| SCHEMBL14282348 | 0.84 | NPBWR1 (0.48) | NPBWR1MCHR1NPSR1ALDH1A1 | |
| SCHEMBL14282378 | 0.84 | NPBWR1 (0.53) | NPBWR1MCHR1NPSR1ALDH1A1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1497269-B1 | SUBSTITUTED 2-PHENYL-3(2H)-PYRIDAZINONES | BAYER HEALTHCARE AG (DE) | 2008-04-23 | — | — | EP | disclosed |